Company intelligence / Profile preview

MS Artemis Biotech

Hyderabad, Telangana, Indiapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~18
Development stage: Preclinical

Overview

Prior to its merger with Themis Medicare, Artemis Biotech was one of India's largest suppliers of statins such as Lovastatin and Simvastatin for domestic and international markets. It also manufactured antibiotics and vitamins for global clients. Post-merger, its biotech capabilities contributed to expanding Themis' product portfolio in biotechnology-based pharmaceuticals[5][8].

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small molecules (notably statins, antibiotics, vitamins)
Industry: Biotech

Partnerships

International pharmaceutical companies for contract manufacturing/supply agreements prior to merger[5].

Beyond the preview

Go deeper on MS Artemis Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MS Artemis Biotech.

Explore the full profile